About Hôpitaux de Brabois
Clinical Trials at Hôpitaux de Brabois
During the past decade, Hôpitaux de Brabois conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpitaux de Brabois" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "United Therapeutics" with 2 trials
sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Celgene Corporation"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpitaux de Brabois"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Intergroupe Francophone du Myelome" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hôpitaux de Brabois
According to Clinical.Site data, the most researched conditions in "Hôpitaux de Brabois" are
"Crohn's Disease" (2 trials), "Multiple Myeloma" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Acute Graft Versus Host Disease in Intestine" (1 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Hôpitaux de Brabois" in a lesser frequency.
Clinical Trials Intervention Types at Hôpitaux de Brabois
Most popular intervention types in "Hôpitaux de Brabois" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (2 trials), "Rituximab" (2 trials), "Bevacizumab" (1 trials) and "CC-5013" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpitaux de Brabois
The vast majority of trials in "Hôpitaux de Brabois" are
15 trials for "All" genders.
Clinical Trials Status at Hôpitaux de Brabois
Currently, there are NaN active trials in "Hôpitaux de Brabois".
1 are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Hôpitaux de Brabois,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpitaux de Brabois, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".